The parasympathetic nervous system is responsible for maintaining normal intestinal and bladder function, contracting the smooth muscle by releasing the neurotransmitters acetylcholine (ACh) and ATP and relaxing sphincters by releasing nitric oxide. ACh is the main transmitter released and smooth muscle contraction is mediated via a mixed M2/M3 receptor population; M3 receptors acting via phospholipase C and M2 receptors acting via inhibition of adenylate cyclase. In ileal, colonic, gastric and bladder (detrusor) smooth muscle the density of M2 receptors is far greater than the density of M3 receptors, the M2:M3 ratio being 3:1 in most species including man. Despite the predominance of M2-receptors, direct contraction of intestinal and detrusor smooth muscle is mediated via the M3-receptor subtype and only this subtype is involved in contraction in vitro. Furthermore, knocking out the M3-receptor gene can have severe consequences on intestinal and bladder responses. In some tissues however M2-receptors may mediate an indirect "re-contraction" whereby a reduction in adenylate cyclase activity reverses the relaxation induced by β-adrenoceptor stimulation. Thus, intestinal and bladder responses to muscarinic agonists are slightly depressed in M2 receptor knockout mice. The role of receptor subtypes in disease is unclear, but an enhancement of M2 receptor mediated responses has been reported to occur in diabetes. Animal models suggest that M2 receptors may play a greater role in some situations such as in the denervated bladder and intestine. In human disease the mechanisms operating are not so clear. Detrusor sensitivity to muscarinic agonists is enhanced in the neurogenic overactive bladder, but there is controversy surrounding the role of M2 receptors and conflicting results have been reported. Thus, the main muscarinic receptor mediating contraction in normal smooth muscle is the M3 receptor, but M2 receptors are also present and possibly may have an enhanced role in disease.
Introduction
The lower urinary tract and the gastrointestinal tract receive a dense nervous innervation Correspondence to: Dr. R. Chess-Williams, Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield S10 2TN, UK Phone: +44-114-2224680 Fax: +44-114-2765413 e-mail: R.Chess@sheffield.ac.uk from the lumbosacral parasympathetic outflow and it is this system that exerts the major influence on activity. A sympathetic innervation also exists, and interactions between the systems operate at a prejunctional and postjunctional level. The main neurotransmitter released within the parasympathetic system is acetylcholine (ACh), but non-adrenergic, non-cholinergic transmitters are also co-released along with Ach (Burnstock, 2001a; 2001b) . Thus ATP, nitric oxide and peptides such as VIP are often co-released with Ach. However the main transmitter remains ACh and the receptors mediating postganglionic responses are the muscarinic receptors.
Although not located on smooth muscle, muscarinic receptors at other sites in the bladder and gastrointestinal tract also influence smooth muscle contraction in these systems. In both the lower urinary tract and the gastrointestinal tract muscarinic receptors are found prejunctionally where they influence the release of neurotransmitter from autonomic nerves. Thus, prejuctional M1 receptors enhancing Ach release have been identified in the bladder of several species (for review see Somogi and de Groat, 1999) and also in the gastrointestinal tract (Kortezova et al., 1998) . M2 receptors and/or possibly M4 receptors are also found prejunctionally in the bladder (Somogi and de Groat, 1999) and the rat anoccocygeus muscle (Lambrecht et al., 1999) , where they inhibit transmitter release. In the bladder, when nerves are stimulated at physiological frequencies, muscarinic receptor stimulation results in enhanced smooth muscle responses, the enhancement being susceptible to blockade by pirenzipine suggesting that it is the prejunctional M1 receptors that predominate under normal physiological conditions (Somogo et al., 1994) . Muscarinic receptors are also found on the urothelium lining the bladder where their activation results in the release of an unidentified factor that inhibits contraction of the underlying smooth muscle (Hawthorn et al., 2000) . A similar situation exists in the rat bladder, where muscarinic receptor stimulation causes the release of an unidentified relaxing factor that can inhibit smooth muscle contraction (Fovaeus et al., 1999) . However the factor in the rat is released from the detrusor smooth muscle itself and not the urothelium. Thus muscarinic receptors are involved in regulating smooth muscle contraction at several levels within the lower urinary and gastrointestinal tracts.
Muscarinic Receptor Subtypes and Second Messenger Systems
Five muscarinic receptor subtypes have been cloned and defined pharmacologically. The pharmacology of the cloned receptors correlates well with the corresponding native receptors and both have been given the same nomenclature (M1-M5) (Caulfield and Birdsall, 1998) . M1, M3 and M5 receptors couple to Gq/11 guanine nucleotide binding proteins and alter cellular activity by stimulating phospholipase C and generating the second messengers inositol trisphosphate (IP3) which induces the release of calcium from intracellular stores and diacylglycerol (DAG) which causes the influx of extracellular calcium to induce responses (Caulfield and Birdsall, 1998) . M2 and M4 receptors couple to Gi proteins to induce responses via an inhibition of adenylate cyclase (Peralta et al., 1988) , a reduction in cAMP levels and smooth muscle relaxation. A number of other putative pathways may also be activated following M2 receptor stimulation. These include the activation of a non-selective cation channel (Bolton and Zholos, 1997) , an inhibition of potassium channels (KATP and BK) and the activation of rho kinase leading to sensitization of the contractile machinery to calcium (Togashi et al., 1998) .
Muscarinic Receptor Subtypes in Bladder and Gastrointestinal Smooth Muscle
Which receptor subtypes are involved in mediating contraction of the lower urinary and gastrointestinal tracts has received significant attention in recent years because of the obvious therapeutic potential of selective muscarinic antagonists in the treatment of the overactive bladder and irritable bowel syndrome. In bladder and gastrointestinal smooth muscle, both the M2 and M3 receptors are present at the mRNA and protein level. Thus Northern blot analysis and RT-PCR studies have identified mRNA for M2 and M3 in the bladder of rats (Maeda et al., 1988; Mimata et al., 1997) , pig (Maeda et al., 1988) and human (Yamaguchi et al., 1996) . In human bladder (Yamaguchi et al., 1996) , pig bladder (Maeda et al., 1988) and rat gastric smooth muscle (Lin et al., 1997) only the M2-and M3 receptor transcripts appear to be present. Furthermore, receptor immunoprecipitation studies have identified the presence of M2 and M3 receptor protein, but not the M1, M4 or M5-receptor protein in rat, guinea-pig, rabbit and human bladder (Wang et al., 1995) . Some of the early radioligand binding studies reported the exclusive presence of M2 receptors in the bladder of various species, but more recent findings with more selective drugs have confirmed the presence of both M2 and M3 receptor subtypes, although the density of M2 receptors is usually far greater than that of the M3 subtype. Thus M2 receptors outnumber M3 receptors by a factor of 3 in the bladders of most species but may be as high as 9 in some species like the rat (Wang et al., 1995) . A similar situation has been found for gastrointestinal smooth muscle where M2 receptors have been shown to be present in greater density than M3 in the guinea pig ileum (Michel and Whiting, 1988) and canine colon (Zhang and Buxton, 1991) .
Receptor Subtypes Mediating DIRECT Contraction
The in vitro responses of isolated strips of gastrointestinal or lower urinary tract tissue following stimulation with agonists such as carbachol or oxotremorine have been examined in many species including humans. In all species so far examined, the responses of isolated tissue preparations appear to be mediated exclusively via the M3-muscarinic receptor subtype, with M3-receptor selective antagonists such as 4-DAMP having a high affinity for the receptor whilst M2-receptor selective antagonists like methoctramine having a relatively low affinity. Furthermore, wherever Schild analysis has been performed the plots for these antagonists have slopes of unity indicating that the M3 receptor is the only muscarinic subtype involved in mediating contractile responses to muscarinic agonists in vitro. Thus, direct smooth muscle contraction is mediated via the M3 receptor subtype in the cat oesophagus (Preiksaitis and Laurier, 1998) , rat stomach (Lin et al., 1997) , guinea pig and dog ileum (Honda et al., 1993; Shi and Sarna, 1997) , guinea pig common bile duct (Karahan et al., 1991) , guinea pig colon (Ehlert, 1999) , guinea pig taenia caeci (Shen and Mitchelson, 1998) and rat anoccocygeus muscle (Weiser et al., 1997) . Similarly, in the lower urinary tract, responses of the bladder have been shown to be mediated via M3 receptors in all species so far examined (for review see ChessWilliams, 2002) including the human bladder (Chess- Fetscher et al., 2002) .
In several studies, correlation plots have also been constructed where the affinities of a range of antagonists for the intestinal or detrusor smooth muscle have been plotted against affinities for the same antagonists obtained in radioligand binding studies with the five cloned receptor subtypes. In both the intestinal (Ehlert et al., 1997) and detrusor muscle (Sellers et al., 2000; Chess-Williams, 2002 ) the best correlations have been obtained against the cloned M3 receptor confirming that this receptor, which comprises the minority of the muscarinic receptor population in these tissues, is responsible for mediating direct contraction.
The dominant role of the M3 receptor subtype has been confirmed in second messenger studies of smooth muscle and muscarinic receptor induced increases in PI turnover have been noted in guinea-pig, rat and human bladder (Noronha-Blob et al., 1989; Andersson et al., 1991; Mimata et al., 1997) and the rat ileum (Cabdell et al., 1990) and canine colon (Zhang and Buxton, 1991) . Furthermore, the receptor mediating these responses has the pharmacological characteristics of the M3 receptor subtype, and M3-antagonists such as 4-DAMP block the second messenger response with a high affinity (Harriss et al., 1995) . However M2 receptors are present and can be shown to be functional at a second messenger level where both an increase in phosphoinositide turnover (M3) and a decrease in cyclic AMP levels (M2) have been recorded in human detrusor smooth muscle following stimulation with carbachol (Harriss et al., 1995) . An interesting finding is that the contribution of M2 receptors to contraction may be greater in some regions than others. This can be seen in the lower urinary tract of the guinea pig , where carbachol increases IP3 levels in the ureter (M3), increases IP3 levels and inhibits cAMP formation in the bladder (M3>M2), while in the urethra a decrease in cAMP is observed before an increase in IP3 formation (M2>M3). An inhibition of cAMP accumulation by muscarinic agonists has also been noted in a number of species including the rabbit, guinea pig and human bladder (Noronha-Blob et al., 1989) , rat ileum (Candel et al., 1990) , canine colon (Zhang and Buxton, 1991) , guinea-pig and rat intestine (Griffin and Ehlert, 1992; Ostrom and Ehlett, 1998) . Furthermore the inhibitory effect of muscarinic agonists on adenylate cyclase can be blocked by antagonists with a high affinity for the M2-receptor.
In some tissues, stimulation of M2 receptors has also been linked to additional transduction mechanisms (Fig. 1) . These include an activation of a non-selective cation channel resulting in depolarization and calcium influx in the guinea pig ileum (Inoet et al., 1994; Bolton and Zholos, 1997) and an inhibition of potassium channels in canine colon (Cole et al., 1989) and gastric smooth muscle (Sims et al., 1990) . The involvement of these mechanisms may not be simple and some of the transduction mechanisms may influence each other. Thus a rise in calcium will facilitate but not activate the non-selective cation channel resulting in a transduction process that not only requires M2 receptor stimulation but also a simultaneous rise in intracellular calcium such as that which occurs during M3 receptor activation (Wang et al., 1997a; Wang et al., 1997b) . This would explain why most tissues have a mixed M2/M3 receptor population.
Gene Knock Out Studies
The relative importance of M2 and M3 receptors in smooth muscle function has been investigated with mice in which the gene for one or both of these muscarinic receptors is absent. In M3 knock out mice (Matsui et al., 2000) , severe defects were observed in smooth muscle function, with bladder contraction to carbachol being reduced by 95% and contraction of the ileum by 75%. In both tissues the remaining responses were antagonised by methoctramine, indicating a small M2 receptor component. Severe urinary retention occurred in male knock-out mice, but no gastrointestinal dysfunction in vitro was observed. These data suggest that smooth muscle contraction is predominantly mediated via M3 receptors but that M2 receptors also play a minor role at least in M3 knock-out animals.
In M2 knock-out mice (Stengel et al., 2000) , as expected cardiac responses to carbachol were abolished. In the ileum and bladders of these animals, responses to the agonist were depressed and the affinity of the M2 receptor-selective antagonist AF-DX116 was reduced. However, these effects were small (only 2-fold change in carbachol EC50 value and antagonist affinity) suggesting a role for M2 receptors in bladder contraction in the mouse, but not a predominant one. This has been confirmed in cystometric studies in receptor knock-out mice where the M3 receptor was found to be the dominant receptor in vivo (Igawa et al., 2005) .
In mice in which both the M3 and M2 receptor gene have been knocked out (Matsui et al., 2002) , responses of the bladder and ileum to muscarinic agonists were completely abolished.
Bladders were distended in males but there was no apparent dysfunction of the gastrointestinal system. Since gastrointestinal responses induced by electrical field stimulation were increased at the same time as responses to muscarinic agonists were abolished, it appears that noncholinergic mechanisms of contraction are upregulated to maintain gastrointestinal function. A similar situation where non-cholinergic mechanisms upregulate to compensate for depressed cholinergic mechanisms has also been proposed for the bladder (Igawa et al., 2005) .
Pharmacological Manipulations of Tissue Receptor Populations
In several tissues including the guinea pig ileum (Ehlert et al., 1995) , colon (Ehlert, 1999) , oesophagus (Eglen et al., 1996) , and the bladders of pigs and guinea pig (Eglen et al., 1994; Hedge et al., 1997) , the role of M2 receptors has been investigated following manipulation of the muscarinic receptor population and second messenger levels. In these tissues, removal of the M3-population with the alkylating agent 4-DAMP mustard (during M2-protection with methoctramine) and elevation of cAMP levels with isoprenaline elicits a response to muscarinic agonists that is at least partially mediated via the M2-receptor subtype (Hedge et al., 1997) . This is in contrast to the normal situation where responses are mediated solely via the M3-subtype.
These experiments suggest that M2-receptors may regulate smooth muscle tone under conditions of high sympathetic activity or where M3-receptors are dysfunctional (Eglen et al., 1994) . In the body of the urinary bladder the predominant effect of sympathetic nerve stimulation is relaxation mediated via β-adrenoceptors and this is thought to facilitate the urine storage phase by relaxing the detrusor smooth muscle. Activation of M2 receptors during cholinergic activation may "switch off" sympathetic inhibitory (β) mechanisms and result in more efficient emptying of the bladder and food transit in the intestine.
Muscarinic Receptors in Disease
The sensitivity of the detrusor muscle to muscarinic agonists is enhanced in several diseased states including diabetes mellitus (Mimata et al., 1995; Kanda et al., 1997) , denervation (Braverman et al., 1998) , bladder outflow obstruction (Speakman et al., 1987) and ageing (Yu et al., 1997) . There may also be changes in receptor subtype function in disease. In the rat bladder M2 receptor density is increased in several disease models (denervation, diabetes) and M2 receptors may contribute significantly to contraction in animal models of disease but few studies have been performed in human.
Diabetes mellitus
Smooth muscle responses to muscarinic agonists are increased in diabetes and two mechanisms appear to be operating. Firstly there is an increase in muscarinic receptor density in diabetic rat bladder (Saito et al., 1997; Kanda et al., 1997) and ureter (Hernandez et al., 1995) , which results in increased IP3 production and a supersensitivity to agonists (Kanda et al., 1997) . The second mechanism is an increase in smooth muscle sensitivity to calcium (Waring and Wendt, 2000) and this may be responsible for the increase in maximum responses observed to carbachol, potassium and electrical field stimulation (Waring and Wendt, 2000) . Both mechanisms operate in detrusor smooth muscle to increase tissue sensitivity and responsiveness, but in the rat ileum only the increase in responsiveness is observed in diabetic rats (Carrier and Aronstam, 1990) suggesting that only the change in calcium sensitivity occurs in the gastrointestinal tract. Northern blot analysis has demonstrated that the increase in total muscarinic receptor density is due to a selective 70% increase in the population of M2-receptors in 2-week diabetic rats (Tong et al., 1999) suggesting a possible enhanced role for this receptor subtype in diabetes.
Denenervation
Denervation of the rat intestine (Osinski and Bass, 1994) or rat bladder (Braverman et al., 1999) results in a supersensitivity of muscarinic responses, which have been shown to be associated with an increase in receptor density. Furthermore in both systems the affinity of M2 antagonists is increased following denervation suggesting a possible increase in role for this receptor subtype in disease.
Enhanced responses to muscarinic receptor stimulation have also been reported in the human neurogenic overactive bladder (Martin et al., 1997) . In the rat bladder M2-receptor density is increased by 60% following denervation and M2 receptors contribute significantly to contraction in this animal model (Braverman et al., 1998) . Such a change in receptor function is not observed in the rat obstructed bladder where responses continue to be mediated via the M3-receptor subtype (Krichevsky et al., 1999) , demonstrating the disease specific nature of these receptor changes. Increases in detrusor muscarinic M2-receptor function and M2-receptor density have also been observed in the rat following pelvic ganglion removal (Braverman et al., 1998) , but the physiological relevance of such changes in M2 receptor are unclear. In human bladder the role of M2 receptors in disease is controversial. In patients with neurogenic overactive bladders, Pontari et al. (2004) have suggested that M2 receptor function is enhanced, but we have been unable to support this finding. In detrusor strips obtained from patients with neurogenic overactive bladders due to spinal injury we have found that the detrusor smooth muscle is supersensitive to muscarinic agonists. However the antagonist affinity values for the M2-selective antagonist methoctramine were similar to the values obtained in normal tissue suggesting no change in M2-receptor function (Stevens et al., 2004) and a role for M2 receptors in human disease has yet to be firmly established.
In conclusion, the role played by muscarinic receptors in the lower urinary and gastrointestinal tracts appear to be similar in the two systems. Direct contraction responses are mediated exclusively via the M3 subtype, despite the main receptor protein in these tissues being the M2 receptor subtype. M2 receptors inhibit adenylate cyclase-mediated relaxation and these receptors may be responsible for switching off sympathetically induced inhibition of smooth muscle contraction during activation of the parasympathetic nervous system. In animal models of disease, M2 receptors appear to have an enhanced role although whether this applies to human disease requires further investigation.
